BioMarin Pharmaceuticals
BMRN
BMRN
525 hedge funds and large institutions have $14.7B invested in BioMarin Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 184 increasing their positions, 178 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
525
Holders Change
-1
Holders Change %
-0.19%
% of All Funds
9.17%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
53
Increased
184
Reduced
178
Closed
52
Calls
$107M
Puts
$173M
Net Calls
-$66.7M
Net Calls Change
-$4.34M
Top Buyers
| 1 |
Dodge & Cox
San Francisco,
California
|
+$188M |
| 2 |
JPMorgan Chase & Co
New York
|
+$76.7M |
| 3 |
California Public Employees Retirement System
Sacramento,
California
|
+$31.2M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$26.4M |
| 5 |
State Street
Boston,
Massachusetts
|
+$19.4M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$86.7M |
| 2 |
BlackRock
New York
|
-$86.7M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$56.2M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$44M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$36.8M |
